As more cell therapies advance through clinical trials towards approval, the explosive excitement in cell therapy development continues to increase, and is fueling the need to develop robust and well-characterized methods of production of cell therapies.

The 2nd Cell Therapy Analytical  Development Summit is dedicated to advancing the next generation of cell therapies, through exploring how to robustly validate assays and advance the characterization of cell immunotherapy analytics to ensure safe, effective and quality cell therapy products.

Join us virtually this December, as the trailblazers of cell therapy analytical development, from the likes of Novartis, Century Therapeutics and Allogene come together to supercharge standardization efforts and novel assays to develop the full analytical package for cell therapies.